While the therapeutic effects of anti-TDP-43 E6 antibody was previously validated in transgenic mouse models of ALS harboring familial TARDBP gene mutations [25,37], we demonstrated here its therapeutic potential in a model of sporadic ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.